ELL2 and plasma cell myeloma: These findings suggested that, similar to the role played in multiple myeloma, reduced ELL2 expression may act an important role in B cell proliferation and make the production of secreted Ig less efficient, which resulted in a higher likelihood of a damaging immunologic response to Gd-IgA1 in the circulation and thereby a higher risk of IgAN.